The problem arises when systems blur distinctions in ways that confuse patients and strain teams. The real fault line in ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

Medicaid programs made more than $200 million in improper payments to healthcare providers between 2021 and 2022 for people ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent ...

Arizona/Utah: The large outbreak on the Arizona-Utah border continues to grow, with 190 cases in Arizona (14 new cases) and ...

At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether ...

The FDA has expanded the indication of ferric maltol (Accrufer) capsules for the treatment of iron deficiency to include ...

Concurrently, low state immunization levels pose a significant and immediate risk, particularly for measles, which is ...

Science Signaling retracted a 2017 paper that linked a specific amyloid form (amyloid-beta 56) to tau pathology after an ...

FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...